1. Home
  2. ANPA vs FTRE Comparison

ANPA vs FTRE Comparison

Compare ANPA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANPA

Rich Sparkle Holdings Limited Ordinary Shares

HOLD

Current Price

$8.84

Market Cap

948.9M

Sector

N/A

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.47

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANPA
FTRE
Founded
2016
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
948.9M
829.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ANPA
FTRE
Price
$8.84
$9.47
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$15.39
AVG Volume (30 Days)
23.7K
1.2M
Earning Date
02-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$2.80
$3.97
52 Week High
$180.64
$18.67

Technical Indicators

Market Signals
Indicator
ANPA
FTRE
Relative Strength Index (RSI) 36.22 42.51
Support Level $8.11 $8.85
Resistance Level $9.43 $11.22
Average True Range (ATR) 0.73 0.62
MACD 1.64 0.16
Stochastic Oscillator 48.44 53.29

Price Performance

Historical Comparison
ANPA
FTRE

About ANPA Rich Sparkle Holdings Limited Ordinary Shares

Rich Sparkle Holdings Ltd is financial printing and corporate services provider which engaged in designing and printing financial print materials in Hong Kong. It service portfolio covers a myriad of deliverables, mainly including listing documents, financial reports, fund documents, circulars and announcements. The company's core business includes (i) financial printing services such as printing, typesetting and translation, (ii) advisory services including Environmental, Social and Governance Report and (iii) other services. Key revenue is generated from Financial printing services.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: